Mania: Psychiatric manifestations of the antiphospholipid syndrome

Psychosomatics

Volumn 49, Issue 5, 2008, Pages 438-441

  Raza, Haniya ^a   Epstein, Steven A ^b   Pao, Maryland ^b   Rosenstein, Donald L ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ENOXAPARIN; LITHIUM; LUPUS ANTICOAGULANT; OLANZAPINE; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; CONCENTRATION LOSS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPNEA; FAMILY HISTORY; HUMAN; IMAGE ANALYSIS; LUNG EMBOLISM; MALE; MANIA; SOMNOLENCE; SYMPTOM; THORAX PAIN; THROMBOSIS;

EID: 51249090949     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.49.5.438     Document Type: Letter

References (30)

1. Wilson WA, et al: International Consensus Statement on Preliminary Classification Criteria for Definite Antiphospholipid Syndrome: Report of an International Workshop. Arthritis Rheum 1991; 42:1309-1311
2. Khamashta MA, Bertolaccini ML, Hughes GRV: Antiphospholipid (Hughes) syndrome. Autoimmunity 2004; 37:309-312
3. Cervera R, Piette JC, Font J, et al: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019-1027
4. Hoffman R, Benz E, Shattil S, et al (eds): Hematology: Basic Principles and Practice, 4th Edition. Churchill Livingstone, 2005, pp 2151-2160
5. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. New Engl J Med 2002; 346:753-763
6. Avcin T, Ambroozic A, Kuhar M, et al: Anticardiolipin and anti-beta(2)-glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001; 40:565-573
7. Avcin T, Cimaz R, Meroni PL: Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002; 11:4-10
8. Canoso RT, deOliviera RM, Nixon RA: Neuroleptic-associated autoantibodies: a prevalence study. Biol Psychiatry 1990; 27:863-870
9. Canoso RT, deOliviera RM: Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. Am J Hematol 1988; 27:272-275
10. Levine SR, Welch KMA: The spectrum of neurologic disease associated with antiphospholipid antibodies. Arch Neurol 1987; 44:876-883
11. Brey RL, Escalante A: Neurological manifestations of antiphospholipid antibody syndrome. Lupus 1998; 7:S67-S74
12. Hughes GRV: Migraine, memory loss, and "multiple sclerosis:" neurological features of the antiphospholipid (Hughes) syndrome. Postgrad Med 2003; 79:81-83
13. Sanna G, Bertolaccini ML, Cuadrado MJ, et al: Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 2003; 42:200-213
14. Chapman J, Rand JH, Brey RL, et al: Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus 2003; 12:514-517
15. Schwartz M. Rochas M, Weller B, et al: High association of anticardiolipin antibodies with psychosis. J Clin Psychiatry 1998; 59:20-23
16. Kurtz G, Muller N: The antiphospholipid syndrome and psychosis. Am J Psychiatry 1994; 151:1841-182
17. Chinnery PF, Shaw PJ, Ince PG, et al: Fulminant encephalopathy due to the catastrophic antiphospholipid syndrome. J Neurol Neurosurg Psychiatry 1997; 62:300-301
18. Granel B, Garcia E, Serratrice J, et al: Asymptomatic intracardiac thrombi and primary antiphospholipid syndrome. Cardiology 1999; 92:65-67
19. Kurita A, Hasunuma T, Mochio S, et al: A young case with multi-infarct dementia associated with lupus anticoagulant. Intern Med 1994; 33:373-375
20. Wilson WB, Smith DB, Wright RR, et al: Sneddon's disease: presenting with visual loss and dementia. J Clin Neuroophthalmol 1988: 255-261
21. Maes M, Meltzer H, Jacobs J, et al: Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatr Scand 1993; 83:160-166
22. Gorman DG, Cummings JL: Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsychiatry Clin Neurosci 1993; 5:37-42
23. Ziporen L, Schoenfeld, Levy Y, et al: Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies: a mouse model. J Clin Invest 1997; 100:613-619
24. Katzav A, Chapman J, Schoenfeld Y: CNS dysfunction in the antiphospholipid syndrome. Lupus 2003; 12:903-907
25. Toubi E, Khamashta MA, Panarra A, et al: Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosis. Am J Med 1995; 99:397-401
26. Sanna G, Bertolaccini ML, Cuadrado MJ, et al: Neuropsychiatric manifestations in systemic lupus erythematosis: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30:985-992
27. Denburg SD, Denburg JA: Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 2003; 12:883-890
28. Cuadrado MJ: Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome). Curr Rheumatol Reports 2002; 4:392-398
29. Sperner-Unterweger B: Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 2005; 65:1493-1520
30. Levenson JL (ed): Textbook of Psychosomatic Medicine. Washington, DC, American Psychiatric Publishing, Inc, 2005, pp 235-239